| 标题： | 2型糖尿病合并慢性肾病患者多重用药安全中国专家共识 |
| title： | Chinese expert consensus on the safety of multiple medications for patients with type 2 diabetes combined with chronic kidney disease |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 治疗 |
| field： | Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 临床医师、临床药师、护理人员、及指南其他潜在使用人员 |
| Guide users： | Clinicians, clinical pharmacists, nursing staff, and other potential users of the guidelines |
| 证据分级方法： | GRADE |
| Evidence grading method： | GRADE |
| 制定单位： | 上海交通大学医学院附属新华医院 |
| Formulating unit： | Shànghǎi jiāotōng dàxué yīxué yuàn fùshǔ xīnhuá yīyuàn 15 / 5000 翻译结果 Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine |
| 注册时间： | 2021-08-10 |
| Registration time： | |
| 注册编号： | IPGRP-2021CN261 |
| Registration number： | |
| 指南制订的目的： | 随着我国老龄化的加剧，T2DM合并CKD老年患者人数日益增长。此类患者在多重用药管理手段和目标制定、合理用药原则等方面具有特殊性，亟待对T2DM合并CKD老年患者的多重用药管理进行规范和细化指导，以改善老年患者的临床预后。 |
| Purpose of the guideline： | With the intensification of aging, the number of elderly patients with T2DM combined with CKD is increasing. Such patients have particularity in terms of multiple drug management methods and target formulation, rational drug use principles, etc. It is urgent to standardize and refine the management of multiple drug management in elderly patients with T2DM combined with CKD to improve the clinical prognosis of elderly patients. |
